Process method suitable for amplification preparation of 4-(6-aminopyridin-3-yl) substituted piperidine
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHANGHAI ZAIQI BIO TECH
- Publication Date
- 2019-12-06
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of synthesis of pharmaceutical intermediates, and in particular relates to a process suitable for the scale-up preparation of 4-(6-aminopyridin-3-yl)-substituted piperidines. Background technique
[0002] In recent years, major pharmaceutical companies in the world have developed a variety of selective CDK4 / CDK6 inhibitors, such as palbociclib developed by Pfizer / Onyx, abemaciclib developed by Eli Lilly, ribociclib developed by Novartis, for the treatment of cancer, cardiovascular Disorders and inflammatory diseases.
[0003] WO2014183520 discloses a selective CDK4 / CDK6 inhibitor with a new structure, and found that the compound with this structure exhibits excellent effects and effects, especially excellent pharmacokinetic absorption activity, and has the following structure: In this inhibitor, 4-(6-aminopyridin-3-yl) substituted piperidine is an important structural fragment, for example: tert-butyl 4-(6-aminopyri...